Singapore markets closed

Eli Lilly and Company (LLY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
323.48+10.02 (+3.20%)
At close: 04:03PM EDT
324.60 +1.12 (+0.35%)
After hours: 07:59PM EDT
Full screen
Loading interactive chart…
  • Motley Fool

    Is This Dividend Growth Stock a Buy?

    The pharma stock Eli Lilly (NYSE: LLY) has surged 13% higher year to date. Let's dive into Eli Lilly's fundamentals and valuation to find out. Eli Lilly reported $7.8 billion in revenue for the first quarter ended March 31, up 14.8% from the year-ago period.

  • Motley Fool

    Why This FDA Approval Is a Game Changer for Eli Lilly

    Eli Lilly (NYSE: LLY) is a top healthcare company that continually finds new ways to grow and create value for its investors. One of the company's recent diabetes treatments has obtained approval from the U.S. Food and Drug Administration (FDA). On May 13, Eli Lilly announced that the FDA had approved Mounjaro (tirzepatide) to treat people with type 2 diabetes.

  • Zacks

    ImmunoGen (IMGN) Ovarian Cancer Drug BLA Gets Priority Review

    ImmunoGen (IMGN) gets priority review from the FDA for the BLA seeking approval for its lead candidate, mirvetuximab soravtansine, for treating platinum-resistant ovarian cancer.